SCHEMBL9599489

SCHEMBL9599489

C=C(C(=O)O)C1NC(=O)CN1C(=O)OCc1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.46
NPC1 O15118 2/20 0.46
RAB9A P51151 2/20 0.46
GAA P10253 1/20 0.46
MAPK1 P28482 1/20 0.46
PSEN1 P49768 2/20 0.46
PSEN2 P49810 2/20 0.46
APH1B Q8WW43 2/20 0.46
NCSTN Q92542 2/20 0.46
APH1A Q96BI3 2/20 0.46
PSENEN Q9NZ42 2/20 0.46
HTR2C P28335 1/20 0.44
CTSK P43235 1/20 0.42
F2 P00734 2/20 0.41
ELANE P08246 2/20 0.41
PARP1 P09874 1/20 0.41
CTSG P08311 1/20 0.41
PREP P48147 2/20 0.41
DDB1 Q16531 1/20 0.41
CRBN Q96SW2 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9599494 0.76 SMN1; SMN2 (0.46) SMN1; SMN2NPC1RAB9AGAAMAPK1
SCHEMBL4397156 0.76 SMN1; SMN2 (0.46) SMN1; SMN2NPC1RAB9AGAAMAPK1
SCHEMBL9599486 0.76 SMN1; SMN2 (0.46) SMN1; SMN2NPC1RAB9AGAAMAPK1
SCHEMBL4397158 0.76 SMN1; SMN2 (0.46) SMN1; SMN2NPC1RAB9AGAAMAPK1
SCHEMBL7527978 0.72 PREP (0.61) PREPKMT2ANPSR1
SCHEMBL7953076 0.70 SMN1; SMN2 (0.53) SMN1; SMN2NPC1RAB9AGAAMAPK1
SCHEMBL19271743 0.70 HTR2C (0.55) SMN1; SMN2NPC1RAB9APSEN1PSEN2
SCHEMBL21872248 0.70 HTR2C (0.55) SMN1; SMN2NPC1RAB9APSEN1PSEN2
SCHEMBL30523584 0.70 HTR2C (0.55) SMN1; SMN2NPC1RAB9APSEN1PSEN2
SCHEMBL6686284 0.70 SMN1; SMN2 (0.52) SMN1; SMN2NPC1RAB9AGAAMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5200406-A Nootropic agents; learning enhancement I.S.F. SOCIETA PER AZIONI (IT) 1993-04-06 US disclosed
US-5130319-A Cognition activators for memory disorders I.S.F. SOCIETA PER AZIONI (IT) 1992-07-14 US disclosed
US-5053422-A Learning-memory enhancers; nootropic agents I.S.F. SOCIETA PER AZIONI (IT) 1991-10-01 US disclosed
EP-0335483-A2 Condensed imidazole derivatives, process and intermediates for their preparation and pharmaceutical compositions containing them. ISF SOCIETA PER AZIONI (IT) 1989-10-04 EP disclosed